Science, Innovation, Curiosity
Leveraging gene tools to design new therapeutic interventions
We are employing vectors to genetically engineer cancer and immune cells to explore new therapeutic interventions and unravel new biological insights.
We are a group of scientists and students with academic formation in biomedical sciences. Ours is not another job, but a responsibility. A big one.
Our team is part of the Unit of Prof. Luigi Naldini, director of the San Raffaele Telethon Institute for Gene Therapy, located at the IRCCS San Raffaele, in Italy, Milan.
Laboratory-Scale Lentiviral Vector Production and Purification for Enhanced Ex Vivo and In Vivo Genetic Engineering.
Mol Ther Methods Clin Dev. 2020 Oct 20;19:411-425.
EVIR: chimeric receptors that enhance dendritic cell cross-dressing with tumor antigens.
www.cancerbiotechnology.com – Thanks for visiting our website!